RxSight financials
$4.90+2.73%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.7M | $30.9M | $32.6M | $30.3M | $33.6M | $37.9M | $40.2M | $35.3M | $34.9M | $29.5M | $28.6M | $22.2M |
| Gross profit | $25.9M | $23.5M | $25.3M | $24.2M | $25.2M | $28.3M | $28.8M | $25.2M | $24.3M | $20.7M | $17.7M | $13.7M |
| Gross margin | 76.7% | 76.1% | 77.5% | 79.9% | 74.9% | 74.8% | 71.6% | 71.4% | 69.5% | 70.1% | 61.8% | 61.9% |
| Operating income | -$13.8M | -$17.8M | -$11.3M | -$12.2M | -$14.0M | -$10.7M | -$8.6M | -$9.2M | -$8.3M | -$10.7M | -$10.9M | -$12.5M |
| Net income | -$12.1M | -$16.0M | -$9.2M | -$9.8M | -$11.8M | -$8.3M | -$5.9M | -$6.3M | -$6.1M | -$9.1M | -$9.2M | -$12.4M |
| Net margin | −35.9% | −51.8% | −28.1% | −32.4% | −35.0% | −22.0% | −14.8% | −17.9% | −17.4% | −30.8% | −32.1% | −55.9% |
| Diluted EPS | $-0.29 | $-0.38 | $-0.22 | $-0.24 | $-0.29 | $-0.20 | $-0.15 | $-0.16 | $-0.16 | $-0.25 | $-0.25 | $-0.35 |
| EBITDA | -$12.8M | -$17.0M | -$10.5M | -$11.3M | -$13.2M | -$9.9M | -$8.1M | -$8.1M | -$7.5M | -$9.6M | -$10.9M | -$11.4M |
| Operating cash flow | -$9.5M | -$10.9M | -$1.1M | -$1.2M | -$4.4M | -$8.8M | -$4.3M | $650.0K | -$4.0M | -$9.3M | -$8.3M | -$8.0M |
| Free cash flow | -$11.5M | -$11.7M | -$2.3M | -$1.8M | -$5.9M | -$9.4M | -$5.1M | -$453.0K | -$5.5M | -$11.3M | -$9.9M | -$8.6M |
| Diluted shares | 41.5M | 41.3M | 41.2M | 41.0M | 40.7M | 40.5M | 40.4M | 39.8M | 38.5M | 36.8M | 36.0M | 35.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.4M | $17.6M | $19.9M | $29.6M | $40.4M | $28.0M |
| Short-term investments | $195.4M | $200.3M | $208.2M | $197.9M | $187.1M | $201.3M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $352.7M | $304.0M | $311.8M | $308.5M | $309.0M | $313.0M |
| Total liabilities | $89.4M | $36.7M | $36.1M | $32.6M | $31.0M | $33.7M |
| Shareholders' equity | $263.3M | $267.3M | $275.7M | $276.0M | $278.0M | $279.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology